A genetic variant is likely putting some children suffering with myocarditis — inflammation of the heart muscle — at higher ...

Gene Fusion Testing Market to reach USD 2.5 Bn by 2035 at 12.1% CAGR, driven by rising cancer incidence and demand for ...

A genetic variant is likely putting some children suffering with myocarditis—inflammation of the heart muscle—at higher risk ...

A 46-year-old man with advanced lung cancer recovered after doctors used Next Generation Sequencing to identify a rare ALK fusion mutation and treat him with targeted therapy instead of chemotherapy.

This article was reviewed by Felix Gussone, MD. What Is Biomarker Testing? How It Works and Why It Matters for Men’s Health ...

India’s pioneering clinical geneticist, Dr. Annie Q. Hasan, breaks down how genes shape health, disease, and daily medical ...

Analysts launch bullish coverage on BillionToOne as its IPO surge, prenatal growth, and molecular diagnostics platform drive ...

The point-of-care (POC) molecular diagnostics market is steadily expanding, with a compound annual growth rate (CAGR) of approximately 6%. This growth is fueled by a growing need for fast, ...

USA Esoteric Testing Market is expected to show increasing and is expected to grow at a CAGR of ~$% from 2022 to 2028 with the need for early detection & diagnosis & rapid technological advancements ...

For the first time, clinicians and patients will have access to an integrated view of genotype (Myriad’s MyRisk with RiskScore test) and phenotype (Clairity Breast) through MagView’s Luminary Risk ...

Looking for an honest Hertility review? One editor took an at-home fertility test and shares details on the cost of Hertility ...

Clairity, Myriad Genetics, Inc. (NASDAQ: MYGN), and MagView, today announced a joint collaboration in an effort to identify ...